Acetylome and phosphoproteome modifications in imatinib resistant chronic myeloid leukaemia cells treated with valproic acid. [electronic resource]
Producer: 20110817Description: 921-31 p. digitalISSN:- 1873-5835
- Acetylation
- Apoptosis
- Benzamides
- Blotting, Western
- Cell Proliferation
- Drug Resistance, Neoplasm
- Electrophoresis, Gel, Two-Dimensional
- Fusion Proteins, bcr-abl -- genetics
- Histone Deacetylase Inhibitors -- therapeutic use
- Humans
- Imatinib Mesylate
- Immunoprecipitation
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive -- drug therapy
- Phosphotyrosine -- metabolism
- Piperazines -- adverse effects
- Protein Kinase Inhibitors -- adverse effects
- Proteome -- analysis
- Pyrimidines -- adverse effects
- RNA, Messenger -- genetics
- Reverse Transcriptase Polymerase Chain Reaction
- Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
- Tumor Cells, Cultured
- Valproic Acid -- therapeutic use
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.